Late-stage trials show weight loss near 30%, with Phase 3 finishing in late 2026. Testing finds about 30% of gray-market peptide samples have problems.
Recap by typeshit. Full story at Clarín.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
A decade-old skin plumping ingredient found new demand from GLP-1 users with hollow cheeks. More than 150 companies now use it, Estée Lauder included.
Mounjaro prescriptions rose 18-fold in 10 months, and Rep. Seo Young-seok says no alerts fire for multi-month supplies or combined use with appetite suppressants.
Loading…